PE20010239A1 - Gen derivado de lawsonia y polipeptidos, peptidos y proteinas de hemolisina relacionados y sus usos - Google Patents
Gen derivado de lawsonia y polipeptidos, peptidos y proteinas de hemolisina relacionados y sus usosInfo
- Publication number
- PE20010239A1 PE20010239A1 PE2000000447A PE0004472000A PE20010239A1 PE 20010239 A1 PE20010239 A1 PE 20010239A1 PE 2000000447 A PE2000000447 A PE 2000000447A PE 0004472000 A PE0004472000 A PE 0004472000A PE 20010239 A1 PE20010239 A1 PE 20010239A1
- Authority
- PE
- Peru
- Prior art keywords
- sequence
- polypeptide
- amino acids
- hemolysin
- peptide
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 11
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 8
- 229920001184 polypeptide Polymers 0.000 title abstract 7
- 108010006464 Hemolysin Proteins Proteins 0.000 title abstract 3
- 241001469654 Lawsonia <weevil> Species 0.000 title abstract 3
- 239000003228 hemolysin Substances 0.000 title abstract 3
- 108090000623 proteins and genes Proteins 0.000 title abstract 3
- 102000004169 proteins and genes Human genes 0.000 title abstract 2
- 150000001413 amino acids Chemical class 0.000 abstract 5
- 241001148567 Lawsonia intracellularis Species 0.000 abstract 2
- 102000015636 Oligopeptides Human genes 0.000 abstract 2
- 108010038807 Oligopeptides Proteins 0.000 abstract 2
- 210000004027 cell Anatomy 0.000 abstract 2
- 239000002773 nucleotide Substances 0.000 abstract 2
- 229960005486 vaccine Drugs 0.000 abstract 2
- 108020004414 DNA Proteins 0.000 abstract 1
- 102000053602 DNA Human genes 0.000 abstract 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 abstract 1
- 210000001744 T-lymphocyte Anatomy 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 230000004727 humoral immunity Effects 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 239000013612 plasmid Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
SE REFIERE A UN POLIPEPTIDO INMUNOGENICO RECOMBINANTE O AISLADO QUE REACCIONA EN FORMA CRUZADA CON UN EPITOPE DE CELULA B O CELULA T DE UN POLIPEPTIDO DE HEMOLISINA DE LAWSONIA SPP DE PREFERENCIA L. INTRACELLULARIS, CAPAZ DE PRODUCIR LA PRODUCCION DE ANTICUERPOS, CONFERIR UNA RESPUESTA INMUNE PROTECTORA; INDUCIR INMUNIDAD HUMORAL; SE SELECCIONA DE a)UN PEPTIDO, OLIGOPEPTIDO, POLIPEPTIDO QUE COMPRENDE UNA SECUENCIA DE AMINOACIDOS CON 70% DE IDENTIDAD DE LA SECUENCIA SEC ID NO:1 DE 251 AMINOACIDOS O LA SECUENCIA DE AMINOACIDOS CODIFICADA POR LA SECUENCIA DE NUCLEOTIDOS QUE CODIFICA A LA HEMOLISINA DE pALK12(ATCC 207195); b)UN PEPTIDO, OLIGOPEPTIDO, POLIPEPTIDO QUE COMPRENDE UNA SECUENCIA DE AMINOACIDOS QUE TIENE POR LO MENOS 50% DE IDENTIDAD DE LA SECUENCIA CON LOS AMINOACIDOS 1 A 50 DE LA SECUENCIA SEC ID NO:1; c)UN HOMOLOGO, ANALOGO, DERIVADO QUE IMITA A UN EPITOPE DE CELULAS B O CELULAS T DE UN POLIPEPTIDO DE HEMOLISINA DE LAWSONIA SPP. SE REFIERE TAMBIEN A VACUNAS QUE COMPRENDEN ADEMAS UN SEGUNDO COMPONENTE QUE COMPRENDE UN PEPTIDO, POLIPEPTIDO O PROTEINA DE L.INTRACELLULARIS ANTIGENO TAL COMO SodC, OmpH, FlgE, AUTOLISINA; TAMBIEN SE REFIERE A UN VECTOR PARA VACUNAS, UNA MOLECULA DE ADN; UN PLASMIDO DESIGNADO pALK12
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13402299P | 1999-05-13 | 1999-05-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20010239A1 true PE20010239A1 (es) | 2001-02-28 |
Family
ID=22461415
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2000000447A PE20010239A1 (es) | 1999-05-13 | 2000-05-12 | Gen derivado de lawsonia y polipeptidos, peptidos y proteinas de hemolisina relacionados y sus usos |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1177213A4 (es) |
| AU (2) | AU775323B2 (es) |
| CA (1) | CA2372105A1 (es) |
| NZ (1) | NZ515363A (es) |
| PE (1) | PE20010239A1 (es) |
| WO (1) | WO2000069906A1 (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6605696B1 (en) | 1999-10-22 | 2003-08-12 | Pfizer, Inc. | Lawsonia intracellularis proteins, and related methods and materials |
| DE60144201D1 (de) | 2000-12-20 | 2011-04-21 | Intervet Int Bv | Lawsonia intracellularis Impfstoff |
| US8834891B2 (en) | 2005-03-14 | 2014-09-16 | Boehringer Ingelheim Vetmedica, Inc. | Immunogenic compositions comprising Lawsonia intracellularis |
| US8398994B2 (en) | 2005-07-15 | 2013-03-19 | Boehringer Ingelheim Vetmedica, Inc. | Lawsonia vaccine and methods of use thereof |
| EP2859900A1 (en) | 2006-12-11 | 2015-04-15 | Boehringer Ingelheim Vetmedica, Inc. | Effective method of treatment of porcine circovirus and lawsonia intracellularis infections |
| TWI551295B (zh) | 2008-04-18 | 2016-10-01 | 英特威特國際股份有限公司 | 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）用疫苗 |
| US20120321656A1 (en) * | 2011-06-20 | 2012-12-20 | Matthias Rath | Oligopeptides and their use for treating infectious diseases |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5885823A (en) * | 1995-06-05 | 1999-03-23 | Nobl Laboratories, Inc. | Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents |
| JP2000502054A (ja) * | 1995-11-30 | 2000-02-22 | アグリカルチャー ビクトリア サービシーズ ピーティーワイ．エルティーディー． | 治療用および診断用の組成物 |
-
2000
- 2000-05-11 EP EP00924978A patent/EP1177213A4/en not_active Withdrawn
- 2000-05-11 WO PCT/AU2000/000439 patent/WO2000069906A1/en not_active Ceased
- 2000-05-11 NZ NZ515363A patent/NZ515363A/en unknown
- 2000-05-11 AU AU43861/00A patent/AU775323B2/en not_active Ceased
- 2000-05-11 CA CA002372105A patent/CA2372105A1/en not_active Abandoned
- 2000-05-12 PE PE2000000447A patent/PE20010239A1/es not_active Application Discontinuation
-
2004
- 2004-10-27 AU AU2004224903A patent/AU2004224903A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU775323B2 (en) | 2004-07-29 |
| AU4386100A (en) | 2000-12-05 |
| EP1177213A1 (en) | 2002-02-06 |
| CA2372105A1 (en) | 2000-11-23 |
| EP1177213A4 (en) | 2002-08-28 |
| NZ515363A (en) | 2003-07-25 |
| WO2000069906A1 (en) | 2000-11-23 |
| AU2004224903A1 (en) | 2004-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA199800973A1 (ru) | Полипептид белка-106 наружной мембраны moraxella catarrhalis, последовательность гена и их применение | |
| IL133056A (en) | Polypeptide containing an immunogenic portion of an m. tuberculosis antigen, a variant thereof and pharmaceutical compositions containing same | |
| IL152886A0 (en) | B-7 related nucleic acids and polypeptides and pharmaceutical compositions containing the same | |
| DE60332645D1 (de) | Ii-key/antigene epitop-hybrid-peptid-vakzine | |
| AR047345A1 (es) | Vacuna para mejorar el crecimiento de animales a base de epitopos neutralizantes | |
| BR9306820A (pt) | Conjugado de um antígeno fracamente imunogênico e um veículo peptideo sintetico vacina processos para melhorar a imunogenicidade de uma molecula de antigeno fracamente imunogenico e para imunizar um hospedeiro mamífero | |
| AR062300A2 (es) | Polipeptido que comprende una porcion inmunogenica de una proteina de prostata o su variante, molecula de adn, vector de expresion, celula huesped composicion farmaceutica, vacuna uso de dichas composiciones y vacunas para preparar medicamentos y proteina de fusion | |
| ES2157060T3 (es) | Sistema de expresion de antigenos heterologos como proteinas de fusion. | |
| ATE366313T1 (de) | Antigene peptide aus neisseria | |
| SE9402089D0 (sv) | Recombinant allergen, fragments thereof, corresponding recombinant DNA molecules, vectors and hosts containing the DNA molecules, diagnostic and therapeutic uses of said allergens and fragments | |
| WO2002008716A3 (fr) | Procede de criblage de peptides utilisables en immunotherapie | |
| PE20010239A1 (es) | Gen derivado de lawsonia y polipeptidos, peptidos y proteinas de hemolisina relacionados y sus usos | |
| ATE349527T1 (de) | Gruppe a streptokokken-impfstoff | |
| PE20010238A1 (es) | GEN DERIVADO DE LAWSONIA Y POLIPEPTIDOS SodC, PEPTIDOS Y PROTEINAS RELACIONADOS Y SUS USOS | |
| WO2003090667A3 (fr) | Composition immunogene ou vaccinale non immunosuppressive, comprenant une proteine e7 mutee du virus hpv-16 | |
| PE20010237A1 (es) | GEN DERIVADO DE LAWSONIA Y POLIPEPTIDOS OmpH, PEPTIDOS Y PROTEINAS RELACIONADOS Y SUS USOS | |
| PE20010316A1 (es) | GEN DERIVADO DE LAWSONIA Y POLIPEPTIDOS, PEPTIDOS Y PROTEINAS FlgE RELACIONADOS Y SUS USOS | |
| DE69935599D1 (de) | Modifizierte hcv peptid-impfstoffe | |
| WO2006116763A3 (en) | Lawsonia intracellularis immunological proteins | |
| DE69928947D1 (de) | Moraxella catarrhalis basb034 polypeptide und verwendungen davon | |
| WO2004056316A3 (en) | Vaccines against hiv-1 tat protein to generate neutralizing antibodies | |
| WO2005062871A3 (en) | Tat linear epitope peptides and conjugates thereof for use in therapeutic compositions and assays | |
| AR004191A1 (es) | Polipeptidos para inducir inmunidad protectora contra la tuberculosis, molecula de adn que los codifica, un vector de expresion, una celula huesped,una composicion farmaceutica, una vacuna, una proteina de fusion, un metodo para detectar la tuberculosis y kit de diagnostico. | |
| WO2001070774B1 (en) | Human t cell response to mhc-binding motif clusters | |
| WO2001042286A3 (en) | Human leucine rich repeat-containing polypeptide and uses therefor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |